Overview

Evaluation of Ceftaroline Fosamil Versus a Comparator in Adult Subjects With Community-acquired Bacterial Pneumonia (CABP) With Risk for Methicillin-resistant Staphylococcus Aureus

Status:
Completed

Trial end date:
2013-12-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to determine whether ceftaroline is effective and safe for the treatment of patients with Community-acquired Bacterial Pneumonia (CABP) at risk for infection due to Methicillin-resistant Staphylococcus aureus (MRSA).

Phase:

Phase 4

Details

Lead Sponsor:

Forest Laboratories

Collaborator:

AstraZeneca

Treatments:

Ceftaroline fosamil
Ceftriaxone
Cephalosporins
Methicillin
Vancomycin